China Reform (China) Market Value

000503 Stock   13.54  0.66  4.65%   
China Reform's market value is the price at which a share of China Reform trades on a public exchange. It measures the collective expectations of China Reform Health investors about its performance. China Reform is trading at 13.54 as of the 23rd of November 2024, a 4.65 percent decrease since the beginning of the trading day. The stock's open price was 14.2.
With this module, you can estimate the performance of a buy and hold strategy of China Reform Health and determine expected loss or profit from investing in China Reform over a given investment horizon. Check out China Reform Correlation, China Reform Volatility and China Reform Alpha and Beta module to complement your research on China Reform.
Symbol

Please note, there is a significant difference between China Reform's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Reform is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Reform's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

China Reform 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to China Reform's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of China Reform.
0.00
11/29/2023
No Change 0.00  0.0 
In 11 months and 27 days
11/23/2024
0.00
If you would invest  0.00  in China Reform on November 29, 2023 and sell it all today you would earn a total of 0.00 from holding China Reform Health or generate 0.0% return on investment in China Reform over 360 days. China Reform is related to or competes with ZYF Lopsking, Jiangxi JDL, Hang Xiao, Dongjiang Environmental, Ye Chiu, Lingyuan Iron, and Eit Environmental. China Reform is entity of China. It is traded as Stock on SHE exchange. More

China Reform Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure China Reform's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess China Reform Health upside and downside potential and time the market with a certain degree of confidence.

China Reform Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for China Reform's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as China Reform's standard deviation. In reality, there are many statistical measures that can use China Reform historical prices to predict the future China Reform's volatility.
Hype
Prediction
LowEstimatedHigh
9.0013.9618.92
Details
Intrinsic
Valuation
LowRealHigh
5.6810.6415.60
Details
Naive
Forecast
LowNextHigh
9.8114.7719.74
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.005-0.005-0.005
Details

China Reform Health Backtested Returns

China Reform is slightly risky given 3 months investment horizon. China Reform Health secures Sharpe Ratio (or Efficiency) of 0.27, which signifies that the company had a 0.27% return per unit of risk over the last 3 months. We were able to analyze thirty different technical indicators, which can help you to evaluate if expected returns of 1.35% are justified by taking the suggested risk. Use China Reform Downside Deviation of 4.23, risk adjusted performance of 0.1954, and Mean Deviation of 3.6 to evaluate company specific risk that cannot be diversified away. China Reform holds a performance score of 21 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.0259, which signifies not very significant fluctuations relative to the market. As returns on the market increase, China Reform's returns are expected to increase less than the market. However, during the bear market, the loss of holding China Reform is expected to be smaller as well. Use China Reform market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to analyze future returns on China Reform.

Auto-correlation

    
  -0.56  

Good reverse predictability

China Reform Health has good reverse predictability. Overlapping area represents the amount of predictability between China Reform time series from 29th of November 2023 to 27th of May 2024 and 27th of May 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of China Reform Health price movement. The serial correlation of -0.56 indicates that roughly 56.0% of current China Reform price fluctuation can be explain by its past prices.
Correlation Coefficient-0.56
Spearman Rank Test-0.52
Residual Average0.0
Price Variance8.63

China Reform Health lagged returns against current returns

Autocorrelation, which is China Reform stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting China Reform's stock expected returns. We can calculate the autocorrelation of China Reform returns to help us make a trade decision. For example, suppose you find that China Reform has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

China Reform regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If China Reform stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if China Reform stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in China Reform stock over time.
   Current vs Lagged Prices   
       Timeline  

China Reform Lagged Returns

When evaluating China Reform's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of China Reform stock have on its future price. China Reform autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, China Reform autocorrelation shows the relationship between China Reform stock current value and its past values and can show if there is a momentum factor associated with investing in China Reform Health.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in China Stock

China Reform financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Reform security.